234 related articles for article (PubMed ID: 31095939)
1. PAQR3 regulates phosphorylation of FoxO1 in insulin-resistant HepG2 cells via NF-κB signaling pathway.
Chen L; Sun X; Xiao H; Xu F; Yang Y; Lin Z; Chen Z; Quan S; Huang H
Exp Cell Res; 2019 Aug; 381(2):301-310. PubMed ID: 31095939
[TBL] [Abstract][Full Text] [Related]
2. Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt signaling pathway.
Hao J; Chen C; Huang K; Huang J; Li J; Liu P; Huang H
Eur J Pharmacol; 2014 Dec; 745():152-65. PubMed ID: 25310908
[TBL] [Abstract][Full Text] [Related]
3. Progestin and AdipoQ Receptor 3 Upregulates Fibronectin and Intercellular Adhesion Molecule-1 in Glomerular Mesangial Cells
Zou Y; Chen Z; Li J; Gong W; Zhang L; Xu F; Chen L; Liu P; Huang H
Front Endocrinol (Lausanne); 2018; 9():275. PubMed ID: 29930535
[TBL] [Abstract][Full Text] [Related]
4. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
[No Abstract] [Full Text] [Related]
5. Erythropoietin ameliorates PA-induced insulin resistance through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and inhibits the inflammatory response in HepG2 cells.
Zhang H; Ge Z; Tang S; Meng R; Bi Y; Zhu D
Mol Med Rep; 2017 Aug; 16(2):2295-2301. PubMed ID: 28656239
[TBL] [Abstract][Full Text] [Related]
6. Carpachromene Ameliorates Insulin Resistance in HepG2 Cells via Modulating IR/IRS1/PI3k/Akt/GSK3/FoxO1 Pathway.
Alaaeldin R; Abdel-Rahman IAM; Hassan HA; Youssef N; Allam AE; Abdelwahab SF; Zhao QL; Fathy M
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946711
[TBL] [Abstract][Full Text] [Related]
7. Systems-wide Experimental and Modeling Analysis of Insulin Signaling through Forkhead Box Protein O1 (FOXO1) in Human Adipocytes, Normally and in Type 2 Diabetes.
Rajan MR; Nyman E; Kjølhede P; Cedersund G; Strålfors P
J Biol Chem; 2016 Jul; 291(30):15806-19. PubMed ID: 27226562
[TBL] [Abstract][Full Text] [Related]
8. Nucleophosmin/B23 contributes to hepatic insulin resistance through the modulation of NF-κB pathway.
Wang X; Ma H; Wang X
Biochem Biophys Res Commun; 2019 Apr; 511(2):214-220. PubMed ID: 30799086
[TBL] [Abstract][Full Text] [Related]
9. TRAF1 knockdown alleviates palmitate-induced insulin resistance in HepG2 cells through NF-κB pathway.
Zhang W; Tang Z; Zhu X; Xia N; Zhao Y; Wang S; Cui S; Wang C
Biochem Biophys Res Commun; 2015 Nov; 467(3):527-33. PubMed ID: 26449452
[TBL] [Abstract][Full Text] [Related]
10. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
Tian F; Ying HM; Wang YY; Cheng BN; Chen J
Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
[TBL] [Abstract][Full Text] [Related]
11. N
Zhang J; Chen Y; Liu C; Li L; Li P
J Diabetes Res; 2020; 2020():1080152. PubMed ID: 32280711
[TBL] [Abstract][Full Text] [Related]
12. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
13. Irisin alleviates FFA induced β-cell insulin resistance and inflammatory response through activating PI3K/AKT/FOXO1 signaling pathway.
Zheng S; Chen N; Kang X; Hu Y; Shi S
Endocrine; 2022 Mar; 75(3):740-751. PubMed ID: 34546489
[TBL] [Abstract][Full Text] [Related]
14. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
[TBL] [Abstract][Full Text] [Related]
15. ANGPTL8/betatrophin alleviates insulin resistance via the Akt-GSK3β or Akt-FoxO1 pathway in HepG2 cells.
Rong Guo X; Li Wang X; Chen Y; Hong Yuan Y; Mei Chen Y; Ding Y; Fang J; Jiao Bian L; Sheng Li D
Exp Cell Res; 2016 Jul; 345(2):158-67. PubMed ID: 26387753
[TBL] [Abstract][Full Text] [Related]
16. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
17. Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism.
Xiao H; Sun X; Lin Z; Yang Y; Zhang M; Xu Z; Liu P; Liu Z; Huang H
Acta Pharm Sin B; 2022 Jun; 12(6):2887-2904. PubMed ID: 35755276
[TBL] [Abstract][Full Text] [Related]
18. The activation of NF-kappaB through Akt-induced FOXO1 phosphorylation during aging and its modulation by calorie restriction.
Kim DH; Kim JY; Yu BP; Chung HY
Biogerontology; 2008 Feb; 9(1):33-47. PubMed ID: 17972158
[TBL] [Abstract][Full Text] [Related]
19. Polydatin Improves Glucose and Lipid Metabolisms in Insulin-Resistant HepG2 Cells through the AMPK Pathway.
Hao J; Huang K; Chen C; Liang Y; Wang Y; Zhang X; Huang H
Biol Pharm Bull; 2018; 41(6):891-898. PubMed ID: 29863077
[TBL] [Abstract][Full Text] [Related]
20. Effect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome.
Kim DH; Kim SM; Lee B; Lee EK; Chung KW; Moon KM; An HJ; Kim KM; Yu BP; Chung HY
J Nutr Biochem; 2017 Jul; 45():104-114. PubMed ID: 28499186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
